Nkarta to host conference call to discuss updated clinical data from nkx101 nk cell therapy program

South san francisco, calif., june 26, 2023 (globe newswire) -- nkarta, inc. (nasdaq: nktx), a biopharmaceutical company developing engineered natural killer (nk) cell therapies, today announced that it will host a conference call on tuesday, june 27, 2023 at 8:00 a.m.
NKTX Ratings Summary
NKTX Quant Ranking